Cas:11079-07-5 Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate manufacturer & supplier

We serve Chemical Name:Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate CAS:11079-07-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate

Chemical Name:Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate
CAS.NO:11079-07-5
Synonyms:Nickel(II) Disodium Ethylenediaminetetraacetate Hydrate;ETHYLENEDIAMINETETRAACETIC ACID DISODIUM NICKEL SALT;Nickel(2+) sodium 2,2′,2”,2”’-(ethane-1,2-diyldinitrilo)tetraacetate (1:2:1);EthylenediaMinetetraacetic Acid DisodiuM Nickel(II) Salt Hydrate;Nickel(2+) sodium 2,2′,2”,2”’-(1,2-ethanediyldinitrilo)tetraacetate (1:2:1)
Molecular Formula:C10H12N2Na2NiO8
Molecular Weight:392.884
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:614.2ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:139.34000
Exact Mass:391.974243
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3467 6.1/PG 3
Packing Group:


Contact us for information like Nickel(II) Disodium Ethylenediaminetetraacetate Hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Nickel(2+) sodium 2,2′,2”,2”’-(1,2-ethanediyldinitrilo)tetraacetate (1:2:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nickel(2+) sodium 2,2′,2”,2”’-(ethane-1,2-diyldinitrilo)tetraacetate (1:2:1) Use and application,Nickel(2+) sodium 2,2′,2”,2”’-(1,2-ethanediyldinitrilo)tetraacetate (1:2:1) technical grade,usp/ep/jp grade.


Related News: The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate manufacturer Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate supplier The fine chemical industry includes fine chemicals and special chemicals. Fine chemical products have the characteristics of a small amount of production, relatively specific application fields, and long and complex industrial chains. They are mainly used in medicine, pesticides, dyes, liquid crystals and other fields. Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate vendor The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. Ethylenediaminetetraacetic Acid Disodium Nickel(II) Salt Hydrate factory The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said.